131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Clinical trial NCT07015684 · RECRUITING

Trial details

NCT number: NCT07015684
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickling Disorder Due to Hemoglobin S

Start date: 2025-04-28
Primary completion: 2030-03-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.